Fedai Özcan | Clinical Medicine | Innovative Research Award

Published on by Health Scientists

Innovative Research Award

Fedai Özcan

Fedai Özcan is affiliated with Klinikum Dortmund, Germany, and works within the field of Clinical Medicine. His academic profile is presented in connection with the Innovative Research Award by Health Scientists Awards, recognizing the importance of clinical research, scientific advancement, evidence-based medical practice, and contributions toward improving healthcare quality and patient outcomes.

Fedai Özcan
Affiliation Klinikum Dortmund
Country Germany
Subject area Clinical Medicine
Award Innovative Research Award
Event Health Scientists Awards
ORCID 0000-0003-4312-7784

Abstract

Fedai Özcan is identified with Klinikum Dortmund, Germany, in the field of Clinical Medicine. This academic recognition profile presents his professional affiliation and the context of the Innovative Research Award associated with Health Scientists Awards. Clinical medicine encompasses patient assessment, diagnosis, treatment, and the evaluation of approaches that may improve healthcare delivery. Research innovation in this field can involve clinical methods, evidence-based practice, diagnostic strategies, and patient-centred outcomes. A comprehensive assessment of individual contributions requires verified publications, research records, and supporting evidence. These details have not been supplied for this profile and should be confirmed through authoritative sources before publication.[2]

Keywords

Clinical medicine, clinical research, innovative research, evidence-based medicine, patient-centred care, medical research, clinical practice, healthcare outcomes, medical innovation, translational medicine, diagnostic approaches, therapeutic strategies, healthcare quality, research evaluation, scientific recognition.

Introduction

Fedai Özcan is associated with Klinikum Dortmund in Germany and is presented in the subject area of Clinical Medicine. Clinical medicine applies scientific evidence to the prevention, diagnosis, management, and monitoring of disease. Research in this discipline supports the evaluation of clinical practices, the refinement of treatment pathways, and the identification of opportunities to improve patient care. Professional affiliations and researcher identifiers can help readers distinguish academic records and locate relevant scholarly outputs. The ORCID registry provides a persistent identifier for connecting researchers with their professional activities, while publication databases support the discovery of indexed research literature. [1] [2]

Research Profile

Fedai Özcan’s supplied professional profile identifies Klinikum Dortmund, Germany, as his institutional affiliation and Clinical Medicine as his subject area. A detailed account of his clinical responsibilities, specialist interests, academic appointments, and research methods requires additional verified biographical information. ORCID can provide a persistent researcher identifier and may link to records maintained by the researcher or connected scholarly systems. Publication and citation information should be checked against authoritative bibliographic records rather than estimated. [1]

Research Contributions

Fedai Özcan’s specific research contributions cannot be established from the supplied information alone. In clinical medicine, contributions may be assessed through documented clinical studies, peer-reviewed publications, methodological advances, collaborative projects, and evidence of relevance to patient care. Appropriate evaluation considers study design, reproducibility, ethical oversight, and the strength of the evidence supporting reported findings. Individual achievements should be described only when supported by publications, institutional records, or other reliable documentation. These standards help maintain a balanced account of clinical scholarship without attributing unverified discoveries or outcomes to a researcher.

Publications

No publication list, article titles, or digital object identifiers were included in the supplied researcher information. Consequently, specific papers cannot be attributed to Fedai Özcan reliably in this article. Relevant publications should be identified through verified author records and checked against publisher pages or bibliographic databases. Each listed work should include its full title, author sequence, publication venue, year, and DOI when available. Crossref provides a searchable bibliographic metadata service that can assist with locating publication records and validating DOI information. [3]

Research Impact

The impact of clinical research may be examined through scholarly citations, independent replication, implementation in clinical practice, contributions to guidelines, and measurable improvements in patient outcomes. Citation counts and h-index values offer limited quantitative indicators and should be interpreted alongside research quality, disciplinary conventions, authorship, and publication history. No verified bibliometric measurements or documented clinical outcomes have been supplied for Fedai Özcan. Accordingly, this profile does not assign numerical impact values or claim specific changes in healthcare attributable to his work. Reliable assessment requires traceable publications and independently verifiable evidence.[2]

Award Suitability

The Innovative Research Award associated with Health Scientists Awards provides a recognition context for research and scientific contributions. Evaluating a candidate in Clinical Medicine should involve documented originality, methodological rigour, scientific significance, ethical research practices, and potential relevance to clinical care. Fedai Özcan’s institutional affiliation and subject area are provided for this profile, but specific achievements and supporting publications have not been independently established here. A defensible assessment of award suitability should therefore incorporate verified research outputs, evidence of individual contribution, and the award organiser’s published eligibility and evaluation criteria.

Conclusion

Fedai Özcan is presented in this academic recognition profile as a Clinical Medicine professional affiliated with Klinikum Dortmund, Germany. The article outlines the relevance of clinical research, the principles used to evaluate scholarly contributions, and the evidence needed to document research impact. His ORCID identifier provides a route for checking researcher records, while verified publications and institutional sources are necessary to establish specific achievements. Further bibliographic and professional information would support a more comprehensive account of his research activities and provide a stronger evidence base for assessing recognition in the context of the Innovative Research Award.[2]

References

    1. ORCID. (n.d.). ORCID: Fedai Özcan. ORCID.
      https://orcid.org/0000-0003-4312-7784
    2. Özcan, F., Kiziler, F., Brinkkoetter, P., Kühne, L., Knöbl, P., & Brinkhoff, A. (n.d.). Unintended interruption of caplacizumab therapy can compromise outcomes in immune-mediated thrombotic thrombocytopenic purpura: Lessons from two clinical cases.
      https://www.mdpi.com/2077-0383/15/17/6601
    3. Özcan, F., Kiziler, F., & Brinkhoff, A. (n.d.). Acute phosphate nephropathy after oral sodium phosphate bowel preparation: A clinically underrecognized entity illustrated by a series of biopsy-proven cases..
      https://www.preprints.org/manuscript/202609.0439
    4. Health Scientists Awards. (n.d.). Official award website. Health Scientists Awards.
      https://healthscientists.org/

Emine Afşin | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Assoc. Prof. Dr. Emine Afşin | Clinical Medicine | Best Researcher Award 

Associate Professor | Bolu Abant Izzet Baysal University | Turkey

Dr. Emine Afşin is a distinguished medical professional and academic whose career reflects a deep commitment to advancing respiratory medicine and public health through clinical excellence, scientific research, and education. As an Associate Professor at Bolu Abant İzzet Baysal University, she has built a robust portfolio of contributions that span clinical practice, scholarly publications, and multidisciplinary collaborations. Her expertise lies in pulmonary diseases, clinical epidemiology, and patient-centered care, with a strong focus on improving diagnostic accuracy and therapeutic outcomes for individuals affected by chronic and infectious respiratory conditions. Dr. Afşin’s research encompasses a wide range of studies addressing disease pathophysiology, healthcare delivery, and preventive interventions, consistently demonstrating her dedication to evidence-based medicine. Her published works in reputable national and international journals have been widely cited, reflecting the impact and relevance of her findings within the global medical community. Through active participation in collaborative research projects, professional societies, and academic conferences, she has fostered strong partnerships that bridge clinical practice and scientific inquiry. Beyond academia, Dr. Afşin is recognized for her role in enhancing healthcare quality, mentoring young physicians, and advocating for equitable access to respiratory health services. Her work continues to contribute meaningfully to both medical science and society, emphasizing innovation, ethics, and human-centered approaches to healthcare advancement. She has 23 citations from 23 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID
Featured Publications

1. Yılmazer, M., Altındiş, M., Cevrioğlu, S., Fenkci, V., Aktepe, O., & Sırthan, E. (2004). Afyon Bölgesinde yaşayan gebe kadınlarda toksoplazma, sitomegalovirus, rubella, hepatit B, hepatit C seropozitiflik oranları. Afyon Kocatepe Üniversitesi Kocatepe Tıp Dergisi.

2. Oğurlu, M., Sen, S., Polatli, M., Sırthan, E., Gürsoy, F., & Cildağ, O. (2007). The effect of spinal anesthesia on pulmonary function tests in old patients. Tuberkuloz ve Toraks, 55(1), 64–70.

3. Afsin, E., Yaksi, O., Onal, A., & Bacaksiz, E. (2022). Tracheal schwannoma mimicking asthma. International Journal of Neuroscience, 134(5), 436–440. https://doi.org/10.1080/00207454.2021.1999702

4. Afşin, E., & Demirkol, M. E. (2022). Post-COVID pulmonary function test evaluation. Turkish Thoracic Journal, 23(5), 345–350. https://doi.org/10.5152/TurkThoracJ.2022.22023

5.Afşin, E., & Cosgun, Z. (2021). A rare cough complication: Internal oblique muscle hematoma. Radiology Case Reports, 16(5), 1015–1018. https://doi.org/10.1016/j.radcr.2021.01.067

Serhat Gürbüz | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Dr. Serhat Gürbüz | Clinical Medicine | Best Researcher Award 

Doctor of Medicine | University of Health Sciences | Turkey

Dr. Serhat Gürbüz, MD, MSc, is a distinguished Consultant in Orthopedics and Traumatology at the Metin Sabancı Baltalimanı Bone Diseases Training and Research Hospital, University of Health Sciences, Istanbul, Turkey. His professional expertise centers on knee, shoulder, and sports surgery, integrating advanced arthroscopic techniques and evidence-based rehabilitation strategies to restore function and improve patient outcomes. Dr. Gürbüz has contributed substantially to the field through scholarly publications in reputable peer-reviewed and indexed journals, clinical presentations, and collaborative research projects focused on musculoskeletal disorders and joint preservation. His work demonstrates a commitment to combining clinical excellence with translational research, contributing to the evolution of orthopedic surgical standards and innovations in minimally invasive procedures. He has maintained active collaborations with national and international orthopedic research groups and serves as a peer reviewer and academic contributor within the global orthopedic community. Dr. Gürbüz’s clinical practice reflects a deep dedication to advancing patient-centered care, surgical innovation, and academic mentorship, fostering the development of future orthopedic specialists. His academic engagement and research productivity underscore his contribution to scientific knowledge dissemination and the enhancement of evidence-based orthopedic medicine. Through his multidisciplinary collaborations and continuous pursuit of clinical innovation, Dr. Gürbüz has strengthened the bridge between medical research and practical application, ultimately promoting better musculoskeletal health and improving the quality of life for patients across diverse populations. He has 6 citations from 9 documents with an h-index of 2.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

1. Çelikoyar, M. M., Topsakal, O., & Gürbüz, S. (2019). Mobile technology for recording surgical procedures. Journal of Visual Communication in Medicine.

2. Imren, Y., Karslioglu, B., Dedeoglu, S. S., Cabuk, H., Atar, S., Gürbüz, S., … (2021). The effect of gluteus maximus tenotomy in primary total hip arthroplasty with posterior approach: Kinematic analysis of hip extensor strength. Journal of Orthopaedic Surgery.

3. Yüce, A., Yerli, M., Erkurt, N., Gürbüz, S., Çakar, M., & Adaş, M. (2022). Neutrophil-lymphocyte and C-reactive protein–albumin ratios as predictors of re-surgery in adult native knee septic arthritis. Journal of Clinical and Investigative Surgery.

4. Gürbüz, S., Bahar, H., Yavuz, U., Keskin, A., Karslioglu, B., & Solak, Y. (2025). Comparative efficacy of ChatGPT and DeepSeek in addressing patient queries on gonarthrosis and total knee arthroplasty. Arthroplasty Today.

5. Gürbüz, S., Ocak, O., Kir, M. C., Karslioglu, B., & Aki, S. (2025). Hyperchloremia at hospital admission for hip fractures is related with an increase in morbidity and mortality rates. Turkish Journal of Trauma and Emergency Surgery.

Dr. Serhat Gürbüz’s work advances global orthopedic science through innovative surgical techniques, evidence-based clinical research, and multidisciplinary collaborations that enhance musculoskeletal health. His commitment to patient-centered innovation and translational research contributes significantly to improving mobility, recovery, and quality of life in society worldwide.

Yang Zhang | Clinical Medicine | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Yang Zhang | Clinical Medicine | Best Researcher Award 

Director | Department of Laboratory Medicine Chongqing University | China

Dr. Yang Zhang, Ph.D., currently serves as Director of the Department of Laboratory Medicine at Chongqing University Affiliated Renji Hospital and is an Associate Chief Physician, Postdoctoral Fellow in Clinical Laboratory Diagnostics, and doctoral and master’s supervisor at Chongqing University. She earned her Bachelor of Medicine in Laboratory Medicine (2008), Master of Medicine in Clinical Laboratory Diagnostics (2011), and Ph.D. in Clinical Laboratory Diagnostics (2015) from the Third Military Medical University, complemented by a Ministry of Education-sponsored visiting scholarship at Loma Linda University, USA (2012–2015). Her research centers on precision molecular diagnostics in oncology, with a special focus on POCT rapid diagnostic reagents and spectroscopy-based label-free diagnostic techniques. Dr. Zhang has led multiple high-level research projects, including three funded by the National Natural Science Foundation of China, one by the National Key R&D Program, and numerous provincial and military projects, securing over 6.88 million RMB in funding. She has published more than 40 academic papers as first or corresponding author, with 15 SCI-indexed articles, an H-index of 24, and a single paper cited over 280 times. Her scholarly contributions extend to 12 Chinese invention patents, 1 international PCT patent, and five co-edited scientific monographs, including works on molecular diagnostics and terahertz applications. Dr. Zhang’s achievements have been recognized with numerous honors, such as Chongqing High-Level Young Medical Talent (2022), the “Top Ten Young Scientists in Shapingba District” (2022), First Prize in the Chongqing Association for Science and Technology Innovation (2023), and the National Laboratory Medicine Science and Technology Innovation Award (2021). She also serves as a reviewer for the NSFC and contributes to several national professional committees in laboratory medicine. She has 1044 citations from 43 documents with an h-index of 16.

Profile: Scopus | ORCID 

Publications

1. Zhang, Y. (2020). ENT1 inhibition attenuates apoptosis by activation of cAMP/pCREB/Bcl2 pathway after MCAO in rats. Experimental Neurology, 331, 113362.

2. Zhang, Y. (2020). Identification of immune-related prognostic biomarkers based on the tumor microenvironment in 20 malignant tumor types with poor prognosis. Frontiers in Oncology, 10, 1008.

3. Tian, H., Yuan, C., Liu, Y., Xia, K., Li, M., Xie, F., Chen, Q., Chen, M., Fu, W., & Zhang, Y. (2020, July 28). A sample-to-answer quantification platform for point-of-care testing of circulating microRNAs based on allosteric spherical nanoprobe. Preprint.

4. Zhang, Y. (2020). Evaluation of the reliability of six commercial SERS substrates. Plasmonics, 15(5), 1323–1332.

5. Zhang, Y. (2020). Dataset concerning plasmonic thermal destruction of murine melanoma by gold nanoparticles obtained by green chemistry. Data in Brief, 30, 105370.